Skip to main content

Table 6 Percent of patients with reached PA-level ≥ 5p at 6-month follow-up, analysed with 1–2 baseline predictive correlates

From: Which patients benefit from physical activity on prescription (PAP)? A prospective observational analysis of factors that predict increased physical activity

Correlate of PA (n) Reached PA-level (≥ 5p)
% of patients p valuea phi coefficient
Positive values Negative values   
SEE (171/115) 44.4 38.7 0.294 0.06
PREP (183/165) 47.0 37.6 0.076 0.10
CONF (180/167) 48.3 35.9 0.019 0.12
BMI (131/226) 50.4 39.4 0.043 0.11
PCS (182/162) 46.2 37.7 0.111 0.09
SEE/PREP (109/92) 49.5 38.0 0.102 0.12
SEE/CONF (107/94) 47.7 34.0 0.050 0.14
SEE/BMI (70/106) 54.3 37.7 0.031 0.16
SEE/PCS (96/79) 47.9 34.2 0.067 0.14
PREP/CONF (128/112) 49.2 33.0 0.011 0.16
PREP/BMI (62/100) 53.2 32.0 0.007 0.21
PREP/PCS (101/80) 50.5 33.8 0.024 0.17
CONF/BMI (65/105) 50.8 28.6 0.004 0.22
CONF/PCS (103/85) 51.5 31.8 0.007 0.20
BMI/PCS (78/113) 48.7 31.9 0.019 0.17
  Low values High values   
PABL (70/85) 38.7 47.2 0.101 0.09
  1. PA-level physical activity level according to ACSM/AHA questionnaire, SEE self-efficacy expectations, PREP readiness to change – prepared, CONF readiness to change – confident, BMI body max index, PCS physical component summary – SF-36, PABL physical activity at baseline. Cut-points regarding positively assessed values were: SEE ≥4.77 points, PREP > 86 mm, CONF > 68 mm, BMI < 30, PCS ≥ 47.06 points. Cut-point regarding low PABL was < 2 points
  2. aP values were determined by Chi-square test for independence
  3. Statistical significance was set at p ≤ 0.05. Statistical significant p-values are presented in bold numbers